Hims & Hers Health (HIMS) Assets Average (2019 - 2026)
Hims & Hers Health (HIMS) posted Assets Average of $2.2 billion for Q1 2026, up 0.77% sequentially from $2.2 billion in Q4 2025, and up 176.49% YoY from $799.6 million in Q1 2025.
Hims & Hers Health (HIMS) Assets Average (2019 - 2026) Analysis & Trends
Hims & Hers Health has reported Assets Average for 8 years, with the latest figure at $2.2 billion in Q1 2026.
- Quarterly Assets Average rose 176.49% year-over-year to $2.2 billion in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $2.2 billion (up 176.49% YoY) and the FY2025 annual result came in at $1.4 billion, up 149.17% from the prior year.
- Assets Average improved to $2.2 billion in Q1 2026 per HIMS's latest filing, from $2.2 billion in the prior quarter.
- Over five years, Assets Average peaked at $2.2 billion in Q1 2026 and troughed at $371.3 million in Q1 2023.
- A 5-year average of $816.0 million and a median of $444.6 million in 2024 frame the typical range for Assets Average.
- The sharpest annual moves came in 2022 and 2025: Assets Average fell 10.88% in 2022, then jumped 279.67% in 2025.
- Over 5 years, Assets Average stood at $374.6 million in 2022, then increased by 14.13% to $427.5 million in 2023, then soared by 53.18% to $654.9 million in 2024, then surged by 235.01% to $2.2 billion in 2025, then gained by 0.77% to $2.2 billion in 2026.
- According to Business Quant data, Assets Average over the past three periods registered $2.2 billion, $2.2 billion, and $2.1 billion for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.98 Bn | 43.02 Bn | - | 43.72 Bn |
| 2 | Teva Pharmaceutical Industries | 43.07 Bn | 39.42 Bn | 2.15 Bn | 39.95 Bn |
| 3 | Zoetis | 31.53 Bn | 29.85 Bn | 1.05 Bn | 15.12 Bn |
| 4 | Takeda Pharmaceutical | 28.60 Bn | 22.80 Bn | 5.10 Bn | 98.59 Bn |
| 5 | United Therapeutics | 22.13 Bn | 19.47 Bn | 683.80 Mn | 6.97 Bn |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn | 35.94 Bn |
| 7 | Neurocrine Biosciences | 15.53 Bn | 15.14 Bn | 935.80 Mn | 5.13 Bn |
| 8 | Elanco Animal Health | 11.69 Bn | 11.16 Bn | 798.00 Mn | 13.39 Bn |
| 9 | Dr Reddys Laboratories | 10.13 Bn | 9.97 Bn | - | 5.97 Bn |
| 10 | Hims & Hers Health | 7.49 Bn | 6.65 Bn | 480.80 Mn | 2.95 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 2.95 Bn |
| Mar 31, 2026 | 2.21 Bn |
| Dec 31, 2025 | 2.19 Bn |
| Sep 30, 2025 | 2.06 Bn |
| Jun 30, 2025 | 1.38 Bn |
| Mar 31, 2025 | 799.63 Mn |
| Dec 31, 2024 | 654.90 Mn |
| Sep 30, 2024 | 541.38 Mn |
| Jun 30, 2024 | 464.30 Mn |
| Mar 31, 2024 | 444.65 Mn |
| Dec 31, 2023 | 427.53 Mn |
| Sep 30, 2023 | 401.87 Mn |
| Jun 30, 2023 | 383.10 Mn |
| Mar 31, 2023 | 371.32 Mn |
| Dec 31, 2022 | 374.58 Mn |
| Sep 30, 2022 | 381.40 Mn |
| Jun 30, 2022 | 381.00 Mn |
| Mar 31, 2022 | 401.31 Mn |
| Dec 31, 2021 | 420.33 Mn |
| Sep 30, 2021 | 383.88 Mn |